Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI) is a publicly traded Healthcare sector company. As of July 27, 2026, SCNI trades at $0.24 with a market cap of $1.19M and a P/E ratio of 0.00. SCNI moved +3.04% today. Year to date, SCNI is -67.92%; over the trailing twelve months it is -89.25%. Its 52-week range spans $0.21 to $6.18. Rallies surfaces SCNI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Scinai Appoints Eilon Elmalem as Yavne CDMO Site Head Effective June 14, 2026: Scinai Biopharma Services has appointed Eilon Elmalem as Site Head of its Yavne CDMO facility, effective June 14, 2026, where he will oversee operations and engineering activities. Elmalem brings over 20 years of biopharma engineering and operations leadership from roles at Merck and Sigma-Aldrich Millipore, supporting planned facility expansion.
| Metric | Value |
|---|---|
| Price | $0.24 |
| Market Cap | $1.19M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.18 |
| 52-Week Low | $0.21 |
| Volume | 32 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
SCNI analyst coverage data. Average price target: $0.00.